Summary:
The purpose of this study is to evaluate the effectiveness of an investigational medication for Major Depressive Disorder. The study consists of 2 fMRI scans and an 8-week outpatient study treatment period followed by a one-week safety follow up period. All procedures and study visits will take place at the Mood and Anxiety Disorders Program at Mount Sinai in New York, NY.
Qualified Participants Must:
• Male or Female, Ages 18-65
•
Diagnosis of Major Depressive Disorder and currently experiencing a Major Depressive Episode
•
Be in good physical health as ascertained by medical history, physical examination, and clinical laboratory evaluations
•
Have no history of bipolar disorder, schizophrenia, or schizoaffective disorder
•
Have no seizure disorder, strokes or tumor
Qualified Participants May Receive:
Compensation will be provided